Prof John Gordon @profcelentyx.bsky.social · 31/10/2025Thrilled and honoured to be invited onto the Scientific Advisory Panel of the Centre for Human-Specific Research 😊 humanspecificresearch.org 010
Prof John Gordon @profcelentyx.bsky.social · 30/07/2025Dr Neil Bodie (June 13, 1955 - July 19, 2025) It is with a heavy heart that I report the sad news that my "LinkedIn Friend" & Colleague Dr Neil Martin Bodie, passed away on July 19th. For more about Neil please see: www.linkedin.com/feed/update/... R.I.P. Dear Friend Thoughts are with his family 110
Prof John Gordon @profcelentyx.bsky.social · 13/04/2025#ImmunoSky #MedSky #CancerSky #PharmaSky #DrugSky **BREAKING: Massive layoffs hit the rodent workforce!** In a historic shift, the FDA is exploring a future without animal studies for drug approvals. BRILLIANT Joseph Arboleda Velasquez @harvard.edu 🤩👍👏 www.linkedin.com/posts/joseph... 120
Prof John Gordon @profcelentyx.bsky.social · 11/04/2025#CancerSky #ImmunoSky #MedSky #Cancer #Aging #Metabolism #TIME to Watch you Eat' #Age- & #Diet- instructed Metabolic Rewiring of the #TumorImmuneMicroEnvironment #TIME-ly review from @unil.bsky.social authors now breaking at @jem.org rupress.org/jem/article/... 020
Prof John Gordon @profcelentyx.bsky.social · 09/04/2025#ImmunoSky #Immunotherapy #ImmuneRelatedAdverseEvents #Biomarkers #ICOS+ CD4 #Tcells define #Susceptibility to anti-PD1-induced #Lung #Pathology in the #Aged #Bcells #Antibodies #TertiaryLymphoidStructures Breaking Open Access Study @jci-insight.bsky.social insight.jci.org/articles/vie... 030
Prof John Gordon @profcelentyx.bsky.social · 04/04/2025Maximizing activity & selectivity of #TherapeuticAntibodies mediated effector functions using Antibody mixtures Breaking Open Access Study* @tandfresearch.bsky.social #mAbs *https://www.tandfonline.com/doi/full/10.1080/19420862.2025.2480666?src=exp-la#abstract 010
Prof John Gordon @profcelentyx.bsky.social · 29/03/2025#MyeloidCell path to #Malignancy: insights into #Liver #Cancer SUPERLATIVE OPEN ACCESS REVIEW from Christel Ramirez & @leilaakkari.bsky.social at @cp-trendscancer.bsky.social 👏 www.cell.com/action/showP... 021
Prof John Gordon @profcelentyx.bsky.social · 17/03/2025#Cancer #Immunotherapy #TAM -pering with the #TumorMicroEnvironment Therapeutic targeting of tumour-associated macrophage receptors Terrific Open Access Review from @unisouthampton.bsky.social researchers Online @imtadvances.bsky.social @britsocimm.bsky.social academic.oup.com/immunotherap... 042
Prof John Gordon @profcelentyx.bsky.social · 13/03/2025Just back from wonderful First Night gig from the brilliant @dannythechamp.bsky.social supported by the super talented @anniedressner.bsky.social 🎵🎹🎤🎸🥁🎶🏴 Catch them if you can 🤩👍 041
Prof John Gordon @profcelentyx.bsky.social · 19/02/2025#TumorMicroEnvironment | #LymphaticVessels: "The Shape of Things to Come" | Lymphatic #Transport in anti- #Tumor #Immunity & #Metastasis | Breaking Review at @rupress.org @jem.org | rupress.org/jem/article/... 020
Prof John Gordon @profcelentyx.bsky.social · 12/02/2025#Nipocalimab, an immunoselective #FcRn blocker that lowers #IgG and has unique molecular properties #autoimmunity #alloimmunity #therapeuticantibodies Breaking study from @johnsonandjohnson.bsky.social www.tandfonline.com/doi/full/10.... 000
Prof John Gordon @profcelentyx.bsky.social · 11/02/2025On International Day of Women and Girls in Science, remembering the late, great Eva Klein 1925 - 2025 Mother of #NKcells, #BurkittLymphoma lines, & much much more Honoured to have known and shared highly memorable times with Eva @ki.se 🇸🇪 000
Prof John Gordon @profcelentyx.bsky.social · 07/02/2025ICONOCLASTIC NEW STUDY BREAKING at @nature.com #GranzymeK activates the ENTIRE #Complement Cascade MAJOR Implications for #Inflammation Novel Mechanism & #Therapeutic Opportunities for #InflammatoryDiseases www.nature.com/articles/s41... 040